Researchers examined data from 31 trials and found that clinical use of hydroxyethyl starch for acute volume resuscitation among critically ill patients carried a higher risk of death compared with other solutions. Hydroxyethyl starch also raised the risk of severe kidney injury and the need for red blood cell transfusions. The findings appeared in the Journal of the American Medical Association.
Hydroxyethyl starch use may raise risk of death, kidney injury
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan